Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | ADP-RIBOSE (CAS# ); (M-H)- | 1619 | Peak area | HAHA | TNF-alpha |
Reversed phase NEGATIVE ION MODE | ADP-RIBOSE (CAS# ); (M-H)- | 2330 | Peak area | HAHA | IL-17A |
Reversed phase NEGATIVE ION MODE | ADP-RIBOSE (CAS# ); (M-H)- | 2730 | Peak area | BS4 | Untreated |
Reversed phase NEGATIVE ION MODE | ADP-RIBOSE (CAS# ); (M-H)- | 4331 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | ADP-RIBOSE (CAS# ); (M-H)- | 4355 | Peak area | PAK | IL-17A |
Reversed phase NEGATIVE ION MODE | ADP-RIBOSE (CAS# ); (M-H)- | 4965 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | ADP-RIBOSE (CAS# ); (M-H)- | 15971 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | ADP-RIBOSE (CAS# ); (M-H)- | 17218 | Peak area | PAK | Untreated |
Reversed phase NEGATIVE ION MODE | ADP-RIBOSE (CAS# ); (M-H)- | 21494 | Peak area | BS4 | IL-17A |
Reversed phase NEGATIVE ION MODE | ADP-RIBOSE (CAS# ); (M-H)- | 24836 | Peak area | BS4 | TNF-alpha |
Reversed phase NEGATIVE ION MODE | ADP-RIBOSE (CAS# ); (M-H)- | 35008 | Peak area | HAHA | IFN-G |
Reversed phase NEGATIVE ION MODE | ADP-RIBOSE (CAS# ); (M-H)- | 49606 | Peak area | PAK | IFN-G |
Reversed phase NEGATIVE ION MODE | ADP-RIBOSE (CAS# ); (M-H)- | 92679 | Peak area | BS4 | IFN-G |
Reversed phase NEGATIVE ION MODE | ADP-RIBOSE (CAS# ); (M-H)- | Peak area | HAHA | Untreated | |
Reversed phase NEGATIVE ION MODE | ADP-RIBOSE (CAS# ); (M-H)- | Peak area | PAK | TNF-alpha | |
Reversed phase POSITIVE ION MODE | ADP-RIBOSE (CAS# ); (M+H)+[-H2O] | 1340 | Peak area | PAK | TNF-alpha |
Reversed phase POSITIVE ION MODE | ADP-RIBOSE (CAS# ); (M+H)+[-H2O] | 1527 | Peak area | PAK | Untreated |
Reversed phase POSITIVE ION MODE | ADP-RIBOSE (CAS# ); (M+H)+[-H2O] | 1538 | Peak area | PAK | IFN-G |
Reversed phase POSITIVE ION MODE | ADP-RIBOSE (CAS# ); (M+H)+[-H2O] | 1611 | Peak area | HAHA | TNF-alpha |
Reversed phase POSITIVE ION MODE | ADP-RIBOSE (CAS# ); (M+H)+[-H2O] | 1671 | Peak area | HAHA | Untreated |
Reversed phase POSITIVE ION MODE | ADP-RIBOSE (CAS# ); (M+H)+[-H2O] | 1681 | Peak area | HAHA | IFN-G |
Reversed phase POSITIVE ION MODE | ADP-RIBOSE (CAS# ); (M+H)+[-H2O] | 1821 | Peak area | PAK | IL-17A |
Reversed phase POSITIVE ION MODE | ADP-RIBOSE (CAS# ); (M+H)+[-H2O] | 1822 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | ADP-RIBOSE (CAS# ); (M+H)+[-H2O] | 1836 | Peak area | BS4 | Untreated |
Reversed phase POSITIVE ION MODE | ADP-RIBOSE (CAS# ); (M+H)+[-H2O] | 2006 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | ADP-RIBOSE (CAS# ); (M+H)+[-H2O] | 2483 | Peak area | BS4 | IFN-G |
Reversed phase POSITIVE ION MODE | ADP-RIBOSE (CAS# ); (M+H)+[-H2O] | Peak area | BS4 | IL-17A | |
Reversed phase POSITIVE ION MODE | ADP-RIBOSE (CAS# ); (M+H)+[-H2O] | Peak area | BS4 | TNF-alpha | |
Reversed phase POSITIVE ION MODE | ADP-RIBOSE (CAS# ); (M+H)+[-H2O] | Peak area | HAHA | IL-17A | |
Reversed phase POSITIVE ION MODE | ADP-RIBOSE (CAS# ); (M+H)+[-H2O] | Peak area | PAK | TNF-alpha+IL-17A |